Graft Versus Host Disease News and Research

Latest Graft Versus Host Disease News and Research

Consolidation treatment with Y-90 epratuzumab after R-CHOP improves remission in DLBCL lymphoma

Consolidation treatment with Y-90 epratuzumab after R-CHOP improves remission in DLBCL lymphoma

Interim results from Cytheris CYT107 Phase I clinical trial in TCD bone marrow transplant patients

Interim results from Cytheris CYT107 Phase I clinical trial in TCD bone marrow transplant patients

No overall cancer risk in people who donate stem cells

No overall cancer risk in people who donate stem cells

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

New studies answer questions related to stem cell transplant procedures in treating hematologic malignancies

Soligenix third quarter revenues increase to $861,000

Soligenix third quarter revenues increase to $861,000

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

SCT transplantation benefits in Hodgkin's lymphoma is unclear

SCT transplantation benefits in Hodgkin's lymphoma is unclear

G-CSF compound may activate virus, increases risk of infection: Research

G-CSF compound may activate virus, increases risk of infection: Research

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

Gentium announces defibrotide presentations at 33rd World Congress of International Society of Hematology

NeoStem responds to court ruling blocking government funding for embryonic stem cell research

NeoStem responds to court ruling blocking government funding for embryonic stem cell research

FDA OOPD awards Soligenix $1.2M for orBec Phase 3 study in acute gastrointestinal Graft-versus-Host-Disease

FDA OOPD awards Soligenix $1.2M for orBec Phase 3 study in acute gastrointestinal Graft-versus-Host-Disease

Hematopoietic cell transplantation survivors report of  chronic health condition after procedure

Hematopoietic cell transplantation survivors report of chronic health condition after procedure

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

Soligenix’s net loss for second-quarter 2010 decreases to $1,577,000

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Mesoblast schedules formal meeting with FDA to discuss proposed Phase 3 clinical trial program

Kiadis Pharma receives FDA approval for IND to start pivotal clinical study for ATIR

Kiadis Pharma receives FDA approval for IND to start pivotal clinical study for ATIR

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

NeoStem announces presentation on very small embryonic-like stem cells at ISSCR 2010

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

USPTO issues Soligenix patent for use of beclomethasone dipropionate in treatment of IBS

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

RegeneRx Biopharmaceuticals prices underwritten public offering at $0.41 per unit

Soligenix first-quarter revenues decrease to $336,000

Soligenix first-quarter revenues decrease to $336,000